IL147094A0 - Retro-inverso peptides derived from interleukin-6 - Google Patents

Retro-inverso peptides derived from interleukin-6

Info

Publication number
IL147094A0
IL147094A0 IL14709400A IL14709400A IL147094A0 IL 147094 A0 IL147094 A0 IL 147094A0 IL 14709400 A IL14709400 A IL 14709400A IL 14709400 A IL14709400 A IL 14709400A IL 147094 A0 IL147094 A0 IL 147094A0
Authority
IL
Israel
Prior art keywords
retro
interleukin
peptides derived
inverso peptides
inverso
Prior art date
Application number
IL14709400A
Other languages
English (en)
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of IL147094A0 publication Critical patent/IL147094A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL14709400A 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6 IL147094A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13968799P 1999-06-16 1999-06-16
PCT/US2000/040227 WO2000077033A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6

Publications (1)

Publication Number Publication Date
IL147094A0 true IL147094A0 (en) 2002-08-14

Family

ID=22487847

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14709400A IL147094A0 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6
IL147094A IL147094A (en) 1999-06-16 2001-12-13 Retro-inverso peptides derived from interleukin-6
IL190034A IL190034A0 (en) 1999-06-16 2008-03-09 Use of retro-inverso peptides derived from interleukin-6

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL147094A IL147094A (en) 1999-06-16 2001-12-13 Retro-inverso peptides derived from interleukin-6
IL190034A IL190034A0 (en) 1999-06-16 2008-03-09 Use of retro-inverso peptides derived from interleukin-6

Country Status (6)

Country Link
EP (1) EP1183267A4 (xx)
JP (1) JP4786843B2 (xx)
AU (1) AU6540500A (xx)
CA (1) CA2376479A1 (xx)
IL (3) IL147094A0 (xx)
WO (1) WO2000077033A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO1998039357A1 (en) * 1997-03-05 1998-09-11 The Regents Of The University Of California Method of alleviating neuropathic pain
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
AU6540500A (en) 2001-01-02
WO2000077033A1 (en) 2000-12-21
JP2003502343A (ja) 2003-01-21
JP4786843B2 (ja) 2011-10-05
EP1183267A4 (en) 2002-09-18
IL147094A (en) 2011-04-28
CA2376479A1 (en) 2000-12-21
EP1183267A1 (en) 2002-03-06
IL190034A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
PL344341A1 (en) Peptides
GB0014870D0 (en) Peptides
GB0128994D0 (en) Peptides
GB0029777D0 (en) Peptides
EP1185558A4 (en) PEPTIDES WITH PREPTID FUNCTIONALITY
AU2973100A (en) Novel agouti and agouti-related peptide analogs
IL150458A0 (en) Novel haptotactic peptides
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
GB9812675D0 (en) Peptides
IL147095A0 (en) Retro-inverso peptides derived from leukemia inhibitory factor
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
GB9904695D0 (en) Peptide
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
GB0001825D0 (en) Peptides
GB9903408D0 (en) Peptides
GB9908920D0 (en) Peptide
GB9807890D0 (en) Peptides
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
EP1245955A4 (en) CYTOKINE TYPE PEPTIDE
EP1323731A4 (en) NEW PEPTIDES
GB9918597D0 (en) Novel peptides
GB9918603D0 (en) Novel peptides
GB9918606D0 (en) Novel peptides
GB9918601D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides